发明名称 Neoplasia-specific splice variants and methods
摘要 <p>All neoplastic cells express a unique cell-surface ubiquinone (NADH) oxidase with protein disulfide-thiol isomerase with characteristic sensitivity to inhibition by capsaicin, sulfonylureas, adriamycin and certain other compounds. This neoplasia-specific protein is the translational expression production of a particular splice pattern: exon 4 is not translated to become part of the neoplasia-specific protein displayed on the surfaces of the cancer cells. Oligonucleotides which span the splice junctions of the cancer-specific mRNA can be used in RT-PCR assays, for example, having nucleotide sequences as given in SEQ ID NO:4 and in SEQ ID NO:5, which, when positive, are useful in the detection of neoplastic cells in the sample from which the mRNA was derived. Alternatively, transcriptase or real time polymerase chain reaction assays can produce amplification products of cancer-specific sizes. In addition, antisense oligonucleotides which inhibit the expression of the neoplasia-specific transcript are disclosed; these restore the normal phenotype of neoplastic cells into which they are introduced. </p>
申请公布号 EP1739168(A3) 申请公布日期 2007.03.07
申请号 EP20060253346 申请日期 2006.06.27
申请人 PURDUE RESEARCH FOUNDATION 发明人 MORRE, D. JAMES
分类号 C12N9/02;C12N15/53;C12Q1/68 主分类号 C12N9/02
代理机构 代理人
主权项
地址